Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The year's new drugs.

Ann I Graul

    Drug News & Perspectives
    |April 12, 2003
    PubMed
    Summary

    The United States led new drug and diagnostic agent launches, with 35 new chemical entities and biological drugs introduced. Anti-infective, oncolytic, and metabolic therapies were the most active therapeutic areas.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Year's New Drugs & Biologics - 2009.

    Drug news & perspectives·2010
    Same author

    Overcoming the obstacles in the pharma/biotech industry: 2009 update.

    Drug news & perspectives·2010
    Same author

    The year's new drugs & biologics - 2008.

    Drug news & perspectives·2009
    Same author

    Promoting, improving and accelerating the drug development and approval processes.

    Drug news & perspectives·2009
    Same author

    Overcoming the obstacles in the pharma/biotech industry: 2008 update.

    Drug news & perspectives·2009
    Same author

    The year's new drugs.

    Drug news & perspectives·2006

    Area of Science:

    • Pharmaceuticals
    • Drug Development
    • Market Analysis

    Background:

    • Global pharmaceutical markets experienced significant activity with new product introductions.
    • Regulatory approvals facilitate the release of novel therapeutic agents and diagnostics.

    Purpose of the Study:

    • To analyze the landscape of new product launches in the pharmaceutical sector.
    • To identify key markets and therapeutic areas for recent drug and diagnostic introductions.

    Main Methods:

    • Data compilation of new chemical entities, biological drugs, and diagnostic agents.
    • Market share analysis focusing on geographical distribution of launches.
    • Categorization of launched products by therapeutic group.

    Main Results:

    • The United States dominated new product launches, accounting for 62.5% (22 products).
    • A total of 35 new chemical entities and biological drugs, plus two diagnostic agents, entered the market.
    • Anti-infective, oncolytic, and metabolic drugs were the most active therapeutic groups, each with five launches.

    Conclusions:

    • The US market is a primary focus for pharmaceutical innovation and product introduction.
    • Targeted therapeutic areas show concentrated development and launch activity.
    • The data highlights key trends in recent pharmaceutical and diagnostic market expansion.

    Related Experiment Videos